Diamond Biotechnology Co., Ltd
6815
Rank in Stocks
#26400
Diamond Biotechnology Co., Ltd is a company focused on the entire lifecycle of... Diamond Biotechnology Co., Ltd is a company focused on the entire lifecycle of medical equipment and skincare products, from research and development to manufacturing and sales. Operating both domestically within Taiwan and across international markets, the firm's beauty care offerings include well-known lines such as Timera and Diamond Beauty. In addition to its core product activities, the company also provides leasing services for medical apparatus. Diamond Biotechnology was established in 2014 and maintains its headquarters in Taipei, Taiwan.
Share Price
$0.60816495
Last synced: 2026-11-10
Market Cap
$20.42M
Change (1 day)
5.00%
Change (1 year)
-71.82%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Diamond Biotechnology Co., Ltd (6815)
Category
Healthcare
Operating Margin for Diamond Biotechnology Co., Ltd (6815)
Operating Margin as of November 2026 TTM: -9.27%
According to Diamond Biotechnology Co., Ltd's latest financial reports, its current operating margin (TTM) is -9.27%. At the end of 2025 the company had an operating margin of -14.79%.
Operating Margin history for Diamond Biotechnology Co., Ltd from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -9.27% | -37.32% |
| 2025 | -14.79% | -200.75% |
| 2024 | 14.68% | 41.56% |
| 2023 | 10.37% | -2.81% |
| 2022 | 10.67% | -12.33% |
| 2021 | 12.17% | 148.88% |
| 2020 | 4.89% | -76.69% |
| 2019 | 20.98% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 22.24% | -102.40% |
US
|
|
| -3.59% | -99.61% |
US
|
|
| 0.53% | -100.06% |
US
|
|
| 5.28% | -100.57% |
US
|
|
| 0.00% | -100.00% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Diamond Biotechnology Co., Ltd's operating margin
What is Diamond Biotechnology Co., Ltd's operating margin?
Diamond Biotechnology Co., Ltd's operating margin is -9.27%, as of Nov 2026.
What was Diamond Biotechnology Co., Ltd's operating margin in 2025?
In 2025, Diamond Biotechnology Co., Ltd's operating margin was -14.79%, compared with 14.68% in 2024.
How has Diamond Biotechnology Co., Ltd's operating margin changed since 2020?
From 2020 to 2025, Diamond Biotechnology Co., Ltd's operating margin was highest in 2024 (14.68%) and lowest in 2025 (-14.79%).
How does Diamond Biotechnology Co., Ltd's operating margin compare with similar companies?
Diamond Biotechnology Co., Ltd's operating margin (-9.27%) is lower than that of all 5 similar companies listed above. The highest among them is Sirona Dental Systems, Inc., with 22.24%.